IOSP Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
491.4M
+8.4%
453.2M
-0.5%
455.6M
+3.1%
441.9M
+0.5%
439.7M
Cost of Revenue
353.1M
+7.1%
329.7M
+0.5%
328.2M
+0.9%
325.2M
+2.7%
316.5M
Gross Profit
138.3M
+12.0%
123.5M
-3.1%
127.4M
+9.2%
116.7M
-5.3%
123.2M
Operating Expenses
98.6M
+7.5%
91.7M
+13.8%
80.6M
-27.3%
110.8M
+24.5%
89.0M
R&D
14.2M
+7.6%
13.2M
+20.0%
11.0M
-19.7%
13.7M
+0.7%
13.6M
SG&A
84.3M
+7.4%
78.5M
+13.3%
69.3M
-3.6%
71.9M
-3.6%
74.6M
Operating Income
39.7M
+24.8%
31.8M
-32.1%
46.8M
+693.2%
5.9M
-82.7%
34.2M
EBITDA
49.7M
+19.2%
41.7M
-25.8%
56.2M
-7.9%
61.0M
+34.7%
45.3M
Net Income
31.2M
+1.3%
30.8M
-35.0%
47.4M
+267.4%
12.9M
-46.0%
23.9M
EPS (Basic)
$1.25
+1.6%
$1.23
-35.6%
$1.91
+267.3%
$0.52
-44.7%
$0.94
EPS (Diluted)
$1.25
+2.5%
$1.22
-35.8%
$1.90
+265.4%
$0.52
-44.7%
$0.94
Shares (Diluted)
24.7M
-0.6%
24.8M
-0.3%
24.9M
+0.0%
24.9M
-0.5%
25.0M
Innospec (IOSP) โ€” Financials